Tag Archive for Public Companies

USANA Announces Launch of Rise Wellness Protein Pop™ Plus at Costco Stores Nationwide

The brand expands its Protein Pop™ line with a carbonated, clear protein beverage delivering 30 grams of protein per can. 
Salt Lake City, UT – Rise Wellness, a wholly owned subsidiary of USANA Health Sciences, Inc. (NYSE: USNA), announced the expansion of its Protein Pop™ offering, with the launch of Protein Pop™ Plus, a new carbonated, ready‑to‑drink clear protein beverage now available at all 607 Costco locations across the United States. Protein Pop Plus builds on the success of the brand’s original Protein Pop line, offering consumers a bold new way to enjoy high‑protein nutrition in a refreshing, carbonated format.
Protein Pop Plus delivers 30 grams of protein in a 12‑ounce can, combining a blend of whey protein isolate plus bovine collagen into a clear, lightly carbonated beverage designed to drink more like a soda than a traditional protein shake. With zero sugar, no artificial sweeteners, and no caffeine, Protein Pop Plus is positioned as a satisfying alternative for consumers seeking functional nutrition without heaviness or compromise.

“Protein Pop Plus represents the next evolution of our Protein Pop brand,”

said Darin Perry, CEO of Rise Wellness.

“It’s the only clear protein drink in the market with 30 grams of protein, collagen and no artificial sweeteners.

Read more...

Zinzino Publishes 2025 Year-End Report: 51% Growth

Increases Dividend By 50% To SEK 6 After High Growth And Significant Improvement In Profitability. 
Zinzino AB (publ) (ZZ-B.ST), a global direct-sales company, reports that revenue for the fourth quarter of 2025 amounted to SEK 1,035.3 (713.5) million, corresponding to 45% (35%) growth compared with the same period last year. In local currencies, revenue for the fourth quarter increased by 52% compared with the corresponding period last year. EBITDA rose to SEK 175.2 (72.9) million after the EBITDA margin increased to 16.9% (10.2%). The improved EBITDA margin compared to the corresponding period last year was mainly due to stronger gross profit and increased synergies, primarily related to the acquisition of Zurvita.
During the quarter, Zinzino acquired 35% of the shares in Xion International Group with the aim of producing algae using bioreactors, thereby securing a sustainable future supply of omega-3 for the company’s main product, BalanceOil. In addition, the assets of the direct sales company Sanki were acquired to increase distribution power in North and South America, and the Gut Health Test was launched.
For the full year 2025, total revenue amounted to SEK 3,337.5 (2,207.8) million, corresponding to 51% (25%) growth compared with the previous year. EBITDA amounted to SEK 443.4 (250.7) million

Read more...

eXp World Holdings Reports Q4 and Full-Year 2025 Results

Bellingham, WA – eXp World Holdings, Inc. (Nasdaq: EXPI) (the “Company,” “eXp” or “we”), the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced financial results for the fourth quarter and fiscal year ended December 31, 2025.

“2025 was a defining year for eXp Realty, validating our belief that transparency and agent empowerment are the only sustainable paths forward,”

said Leo Pareja, CEO of eXp Realty.

“Our results reflect a year of relentless execution where the industry took notice of our momentum. We aggressively strengthened our value stack, from innovations in our AI-enabled platform to the rollout of the co-sponsor program, and key leadership appointments that position us for scale. We expect 2026 to be a pivotal year as our prior investments begin to yield margin improvements, driven by focused execution.  We will also continue to assess opportunities to accelerate growth, expand our capabilities, and drive long-term shareholder value. We believe our platform is well-positioned to drive durable, profitable growth while combining the speed of innovation with the operational trust our agents rely on to thrive.”
“Our focus this year has been on building a boundary-less platform where technology and community converge,”

said Glenn Sanford, Founder, Chairman and CEO of eXp World

Read more...

Herbalife Reports Q4 and Full-Year Sales Growth

Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA¹ Exceed Guidance.
Los Angeles, CA – Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, reported financial results for the fourth quarter and year ended December 31, 2025.

“We exited 2025 with solid momentum, delivering Q4 and full‑year net sales growth and adjusted EBITDA1 above guidance. Cristiano Ronaldo’s investment in Pro2col reflects our shared ambition to scale personalized nutrition and wellness globally—uniting science, data, AI, innovation, and community to improve the health and performance of millions.”

– Stephan Gratziani, CEO
Highlights
Fourth Quarter 2025

Net sales up 6.3% vs. Q4 ‘24 to $1.3 billion; exceeds guidance

Up 5.5% year-over-year on constant currency basis2; exceeds guidance

Net income attributable to Herbalife of $85.4 million; adjusted net income1 of $47.5 million
Adjusted EBITDA1 of $156.1 million, or $167.7 million on a constant currency basis2; both exceed guidance
Diluted EPS of $0.81; adjusted diluted EPS1 of $0.45

Full-Year 2025

Net sales up 0.9% vs. 2024 to $5.0 billion; exceeds guidance

Includes 160 basis points of foreign currency (“FX”) headwind
Up 2.5% year-over-year on constant currency basis2, exceeds guidance

Net income attributable to Herbalife of $228.3 million; adjusted net income1 of $219.4 million
Adjusted EBITDA1 of $657.6 million, or $713.9 million on a constant currency basis2; both exceed guidance

Credit Agreement EBITDA1 of

Read more...

Herbalife Reports Q4 and Full-Year Sales Growth

Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA¹ Exceed Guidance.
Los Angeles, CA – Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, reported financial results for the fourth quarter and year ended December 31, 2025.

“We exited 2025 with solid momentum, delivering Q4 and full‑year net sales growth and adjusted EBITDA1 above guidance. Cristiano Ronaldo’s investment in Pro2col reflects our shared ambition to scale personalized nutrition and wellness globally—uniting science, data, AI, innovation, and community to improve the health and performance of millions.”

– Stephan Gratziani, CEO
Highlights
Fourth Quarter 2025

Net sales up 6.3% vs. Q4 ‘24 to $1.3 billion; exceeds guidance

Up 5.5% year-over-year on constant currency basis2; exceeds guidance

Net income attributable to Herbalife of $85.4 million; adjusted net income1 of $47.5 million
Adjusted EBITDA1 of $156.1 million, or $167.7 million on a constant currency basis2; both exceed guidance
Diluted EPS of $0.81; adjusted diluted EPS1 of $0.45

Full-Year 2025

Net sales up 0.9% vs. 2024 to $5.0 billion; exceeds guidance

Includes 160 basis points of foreign currency (“FX”) headwind
Up 2.5% year-over-year on constant currency basis2, exceeds guidance

Net income attributable to Herbalife of $228.3 million; adjusted net income1 of $219.4 million
Adjusted EBITDA1 of $657.6 million, or $713.9 million on a constant currency basis2; both exceed guidance

Credit Agreement EBITDA1 of

Read more...

Medifast Announces Fourth Quarter and Full Year 2025 Financial Results

Baltimore, MD – Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the fourth quarter and full year ended December 31, 2025.
Fourth Quarter 2025

Revenue of $75.1 million, with revenue per active earning coach of $4,664
Independent active earning coaches of 16,100
Net loss of $18.1 million, or $1.65 per diluted share (“EPS”), which includes the tax provision charge to establish a non-cash valuation allowance on the Company’s deferred tax balance of $12.1 million (or $1.10 per diluted share)
Cash, cash equivalents, and investment Securities of $167.3 million and no debt

Full Year 2025

Revenue of $385.8 million
Net loss of $18.7 million, or $1.70 per diluted share, which includes the tax provision charge to establish a non-cash valuation allowance on the Company’s deferred tax balance of $12.1 million (or $1.10 per diluted share)

“As we enter 2026, Medifast is moving from defining its business transformation strategy to executing on a new path to growth, leading to profitability as we become wholly focused on optimal metabolic health,”

said Dan Chard, Chairman and Chief Executive Officer of Medifast.

“In the fourth quarter, we saw coach productivity turn positive year-over-year for the first time since 2022, which has historically been a lead indicator of

Read more...

USANA Reports Q4 and Full Year 2025 Results

USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook.
Salt Lake City, Utah – USANA Health Sciences, Inc. (NYSE: USNA), a global leader in direct selling, today announced financial results for its fiscal fourth quarter and fiscal year ended January 3, 2026.

“USANA delivered fourth quarter net sales in line with our preliminary results announced on January 12, 2026,”

said Kevin Guest, Chairman and Chief Executive Officer.

“We began to see signs of stabilization in active customer counts in our core nutritional business as net sales in this segment increased modestly sequentially, led by growth in key markets including mainland China, the United States and Canada. Meanwhile, our omnichannel brands, Hiya and Rise, posted solid year-over-year growth.”

Key Financial and Operating Results

Q4 2025

Q4 2024

FY 2025

FY 2024

Net sales

$226.2

$213.6

$925.3

$854.5

Net (loss) earnings*

$-1.8

$4.5

$10.8

$42.0

Diluted EPS

$-0.10

$0.23

$0.58

$2.19

Adjusted diluted EPS(1)

$0.60

$0.64

$1.93

$2.59

Adjusted EBITDA(2)

$27.3

$25.5

$101.3

$110.3

USANA Active Customers

387,000

454,000

387,000

454,000

Hiya Active Monthly Subscribers

181,700

N/A

181,700

N/A

*Pretax earnings for Q4 2025 totaled $4.0 million with income tax expense of $5.8 million. The adjustment to income taxes during the period, largely as a result of one-time impairment and cost realignment charges, is about $3.1 million greater than what would have been expected using the previously expected 65% tax rate.

Net sales, Net (loss) earnings and Adjusted EBITDA figures

Read more...

Natural Health Trends Reports Fourth Quarter and Full Year 2025 Financial Results

– Net sales decreased 10% year over year, but increased 3% sequentially
– Restructuring initiatives to achieve $1.5 million annualized savings substantially complete
– Declared a quarterly cash dividend of $0.10 per share
Los Angeles, CA – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
Fourth Quarter 2025 Financial Highlights


Revenue of $9.7 million increased 3% compared to $9.5 million in the third quarter of 2025 and declined 10% compared to $10.8 million in the fourth quarter of 2024.


Operating loss was $635,000 compared to $495,000 and $421,000 in the third quarter of 2025 and fourth quarter of 2024, respectively. Excluding restructuring-related charges of $283,000 recognized during the fourth quarter, operating loss would have been $352,000 during the quarter.


Net loss was $588,000, or $0.05 per diluted share, compared to net loss of $431,000, or $0.04 per diluted share, and net income of $176,000, or $0.02 per diluted share, in the third quarter of 2025 and fourth quarter of 2024, respectively. Despite the loss before income taxes, tax expense of $175,000 was recognized in the fourth quarter due to an

Read more...

Nu Skin Enterprises Reports Fourth Quarter and Full-Year 2025 Results Within Guidance

Company provides initial outlook for Q1 and fiscal year 2026, forecasting a return to revenue growth by year’s end. 
Provo, Utah — Nu Skin Enterprises Inc. (NYSE: NUS) announced fourth quarter and full-year 2025 revenue and earnings within guidance with more than 50% growth in earnings for 2025.

“We are pleased to achieve fourth quarter results within our guidance range for both revenue and earnings per share,”

said Ryan Napierski, Nu Skin president and CEO.

“This past year was a pivotal year as we furthered our transformation toward becoming the world’s leading intelligent beauty and wellness platform and laid the groundwork for our 2026 growth initiatives. Looking ahead, we continue to build sales leader alignment in the first half of the year around the global launch of Prysm iO, positioning us for a return to year-over-year revenue growth by year’s end.
“We are now placing Prysm iO intelligent wellness devices into the hands of sales leaders around the world ahead of our consumer launch in the second half of the year. More than 20,000 devices are already in the hands of our sales leaders generating more than 700,000 scans. As we gain greater adoption and more individuals are scanning and receiving their personalized product recommendations,

Read more...

LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan

Salt Lake City, Utah – LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, today announced that after nine years at LifeVantage, Steve Fife, President, Chief Executive Officer and a member of the Board of Directors (the “Board”), has decided to retire in April 2026.
Fife will continue in his role as President and Chief Executive Officer during the transition period to ensure business continuity through his retirement date. The Board is conducting an extensive executive search and anticipates announcing the new CEO in the coming months.

“To ensure continuity and position LifeVantage for continued success, the Board has been carrying out comprehensive succession planning for Steve’s eventual retirement,”

said Raymond Greer, Chairman of the Board of LifeVantage.

“This well-planned transition ensures continuity and positions LifeVantage for continued success. Steve has been an exceptional leader whose strategic insights and focus on operational excellence have been pivotal in transforming the Company’s business and driving growth across multiple dimensions. His commitment to our consultants, customers, employees and shareholders has created a strong foundation for future growth. While we will miss his leadership, we respect his decision to retire and are grateful for his many contributions to LifeVantage.”
“Leading LifeVantage has been one of the

Read more...